Testing effectiveness (Phase 2)Not Yet RecruitingNCT06684509What this trial is testingAtorvaststin and Cardiotoxicity in Acute Myloid LeukemiaWho this might be right forLeukemiaHodgkin Disease Assiut University 46
Testing effectiveness (Phase 2)Ended earlyNCT01050439What this trial is testingUnrelated Donor Transplant for Malignant and Non-Malignant DisordersWho this might be right forLeukemiaLymphomaBone Marrow Failure Syndromes+2 more Columbia University 22
Not applicableStudy completedNCT00602134What this trial is testingBioequivalence Study of 6-Mercaptopurine Under Fasting ConditionsWho this might be right forAcute Lymphoblastic Leukemia Roxane Laboratories 54
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07313852What this trial is testingInotuzumab and Blinatumomab in People With B-cell Acute Lymphoblastic LeukemiaWho this might be right forB-cell Acute Lymphoblastic LeukemiaB-Cell Acute Lymphoblastic Leukemia, AdultB-ALL Memorial Sloan Kettering Cancer Center 26
Not applicableStudy completedNCT00899652What this trial is testingDNA Analysis of Bone Marrow and Blood Samples From Young Patients With Acute Myeloid Leukemia or Acute Lymphoblastic LeukemiaWho this might be right forLeukemia Children's Oncology Group 149
Early research (Phase 1)Study completedNCT00003289What this trial is testingUCN-01 in Treating Patients With Advanced CancerWho this might be right forLeukemiaLymphomaUnspecified Adult Solid Tumor, Protocol Specific Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)UnknownNCT04731974What this trial is testingAcute Concussion and MelatoninWho this might be right forConcussion, MildConcussion, BrainPediatric ALL Children's National Research Institute 254
Large-scale testing (Phase 3)Study completedNCT00430118What this trial is testingCombination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic LeukemiaWho this might be right forLeukemia University Hospital Schleswig-Holstein 4,559
Testing effectiveness (Phase 2)Looking for participantsNCT07007052What this trial is testingPhase II Study Evaluating the Efficacy and Safety of the Combination of Tagraxofusp and Venetoclax in Treatment-naive Blastic Plasmacytoid Dendritic Cell Neoplasm PatientsWho this might be right forBlastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) French Innovative Leukemia Organisation 33
Not applicableStudy completedNCT05190952What this trial is testingDexamethasone & Ketamine as Adjuvants to Bupivacaine for Incisional Infiltration in Pediatric Abdominal OperationsWho this might be right forPediatric ALL Ain Shams University 150
Large-scale testing (Phase 3)UnknownNCT03553238What this trial is testingPrecision Diagnosis Directing HDACi Chidamide Target Therapy for Adult ETP-ALLWho this might be right forLeukemia, AcuteLeukemia, T CellLeukemia, Lymphoblastic Nanfang Hospital, Southern Medical University 70
Testing effectiveness (Phase 2)Looking for participantsNCT06530550What this trial is testingPI3K Inhibitors for the Treatment of Relapsed/Refractory Indolent T/NK-cell LymphomasWho this might be right forLymphoma, T-CellNK-LGL LeukemiaT-LGL Leukemia Institute of Hematology & Blood Diseases Hospital, China 51
Post-approval studies (Phase 4)Study completedNCT00198991What this trial is testingGerman Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003)Who this might be right forAdult Acute Lymphocytic Leukemia Goethe University 1,883
Early research (Phase 1)Study completedNCT00001333What this trial is testingPhase I Study of Intrathecal TopotecanWho this might be right forLeukemiaLymphomaMeningeal Neoplasms National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Study completedNCT02362035What this trial is testingACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic MalignanciesWho this might be right forFollicular Lymphoma (FL)CLLSmall Lymphocytic Lymphoma (SLL)+10 more Acerta Pharma BV 161
Not applicableLooking for participantsNCT06689917What this trial is testingJY231(JY231) Injection for the Treatment of Relapsed or Refractory B Cell Lymphoma/ LeukemiaWho this might be right forB-ALLB-NHL Tongji Hospital 20
Not applicableStudy completedNCT04858568What this trial is testingImmune Responses to COVID-19 Vaccination in Lymphoma PatientsWho this might be right forClassical Hodgkin LymphomaDiffuse Large B Cell LymphomaPrimary Mediastinal B Cell Lymphoma+10 more University Hospital Southampton NHS Foundation Trust 592
Not applicableLooking for participantsNCT07813208What this trial is testingPh+ ALL in Chinese Children: Diagnosis, Treatment, and SurvivalWho this might be right forAcute Lymphoblastic Leukemia, Pediatric The Children's Hospital of Zhejiang University School of Medicine 500
Not applicableEnded earlyNCT00594308What this trial is testingIn-Vivo Activated T-Cell Depletion to Prevent GVHDWho this might be right forAcute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+7 more Indiana University 10
Testing effectiveness (Phase 2)UnknownNCT02846584What this trial is testingA Clinical Research of Sequential CAR-T Bridging HSCT in the Treatment of Relapse/Refractory B-cell MalignanciesWho this might be right forLymphoma, Large B-Cell, DiffuseLeukemia, Lymphocytic, Chronic, B-CellLymphoma，Malignant Southwest Hospital, China 100